Crinetics Pharmaceuticals Inc (CRNX)
56.82
+0.13
(+0.23%)
USD |
NASDAQ |
Nov 04, 16:00
56.82
0.00 (0.00%)
After-Hours: 20:00
Crinetics Pharmaceuticals Profit Margin (Quarterly): -18.56K% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -18.56K% |
| March 31, 2024 | -10.46K% |
| December 31, 2023 | |
| September 30, 2023 | -16.61K% |
| June 30, 2023 | -5.16K% |
| March 31, 2023 | -1.72K% |
| Date | Value |
|---|---|
| December 31, 2022 | -6.35K% |
| September 30, 2022 | -9.15K% |
| June 30, 2022 | -9.65K% |
| March 31, 2022 | -1.11K% |
| December 31, 2021 | -2.86K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-18.56K%
Minimum
Jun 2024
-1.11K%
Maximum
Mar 2022
-8.16K%
Average
-7.75K%
Median
Profit Margin (Quarterly) Benchmarks
| PTC Therapeutics Inc | -53.12% |
| Zevra Therapeutics Inc | -447.9% |
| Clearside Biomedical Inc | -8.44K% |
| Biomea Fusion Inc | -- |
| NovaBay Pharmaceuticals Inc | -66.04% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -42.43% |
| Return on Assets | -37.11% |
| Return on Invested Capital | -42.43% |
| Operating Margin (Quarterly) | -20.75K% |
| Return on Net Operating Assets | -421.4% |